BLFS | BioLife Solutions Inc
Category: Consumer goods
Industry: Medical Instruments & Supplies Quick infos Headquarters: Bothell, Washington, United States Trade prices Volume: Market Cap: 620.88M Prev closed: 38.57 Open: 46.5 High: 47.97 Low: 37.14 52 week low: 8.29 52 week high: 47.97 Dividends: Next ER: May 10, 2023
Earnings History Date EPS / Forecast Revenue / Forecast August 10, 2023 May 10, 2023 -0.32 / -0.2137.7M / 42.92MMarch 16, 2023 -1.15 / -0.161344.26M / 43.4MBeat! November 9, 2022 -0.23 / -0.1640.7M / 42.02MAugust 9, 2022 -1.71 / -0.208940.53M / 39.17MBeat! view more
Historical Data Date Price Open High Low Vol Change ER May 8, 2023 19.16 19.24 19.66
18.81
177K -0.93% May 5, 2023 19.34 18.51 19.67
18.17
246K 8.04% May 4, 2023 17.9 17.69 17.98
17.16
180K 1.13% May 3, 2023 17.7 17.28 18.38
17.25
203K 2.97% May 2, 2023 17.19 17.94 18.37
17.18
191K -5.03% May 1, 2023 18.1 17.77 18.27
17.53
139K 3.08% Apr 28, 2023 17.56 17.58 18.11
17.39
300K -0.34% Apr 27, 2023 17.62 18.16 18.16
17.45
212K -2% Apr 26, 2023 17.98 18.13 18.29
17.89
209K -0.88% Apr 25, 2023 18.14 19.06 19.27
18
276K -6.25% view more
NASDAQ - Nasdaq Stock Market
News
BioLife Solutions GAAP EPS of -$0.23 misses by $0.06, revenue of $40.7M misses by $1.36M seekingalpha.com Nov 10, 2022 5:20 am BioLife Solutions Q3 2022 Earnings Preview seekingalpha.com Nov 9, 2022 6:35 am BioLife Solutions COO Roderick de Greef to retire seekingalpha.com Oct 3, 2022 8:54 pm
BioLife Solutions Announces First Quarter 2021 Financial Results finance.yahoo.com May 14, 2021 4:05 pm
The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping finance.yahoo.com May 14, 2021 8:59 am
The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO finance.yahoo.com May 14, 2021 8:18 am Biolife Solutions Inc (BLFS) Q1 2021 Earnings Call Transcript fool.com May 14, 2021 12:30 am BioLife Solutions GAAP EPS of -$1.71 misses by $1.50, revenue of $40.5M beats by $1.33M seekingalpha.com Aug 10, 2022 4:28 am BioLife Solutions Q2 2022 Earnings Preview seekingalpha.com Aug 9, 2022 5:35 am BioLife Solutions GAAP EPS of -$0.17 beats by $0.09, revenue of $36.22M misses by $1.98M seekingalpha.com May 10, 2022 4:11 am BioLife Solutions gains as Oppenheimer upgrades on valuation seekingalpha.com Apr 25, 2022 10:23 pm BioLife Solutions receives Nasdaq notice for noncompliance seekingalpha.com Mar 21, 2022 2:08 pm BioLife Solutions GAAP EPS of -$0.37 misses by $0.20, revenue of $37.3M beats by $0.87M seekingalpha.com Mar 1, 2022 5:19 am BioLife Solutions Q4 2021 Earnings Preview seekingalpha.com Feb 28, 2022 6:35 am BioLife Solutions EPS beats by $0.09, beats on revenue seekingalpha.com Nov 12, 2021 5:36 am BioLife Solutions Q3 2021 Earnings Preview seekingalpha.com Nov 11, 2021 6:35 am Bio-Techne promoted to S&P 500, replacing Maxim Integrated seekingalpha.com Aug 25, 2021 6:53 am BioLife Solutions EPS misses by $0.03, beats on revenue seekingalpha.com Aug 13, 2021 4:16 am BioLife Solutions to acquire Sexton Biotechnologies in $30M deal seekingalpha.com Aug 9, 2021 8:32 pm BioLife Solutions EPS beats by $0.01, beats on revenue seekingalpha.com May 14, 2021 4:27 am Talk about BioLife Solutions Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 100 HOLD 0 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet